Form 8-K - Current report:
SEC Accession No. 0001005286-25-000106
Filing Date
2025-08-07
Accepted
2025-08-07 16:30:08
Documents
13
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20250807.htm   iXBRL 8-K 25828
2 EX-99.1 lfcr-25q4xex991earningsrel.htm EX-99.1 209045
  Complete submission text file 0001005286-25-000106.txt   372200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20250807.xsd EX-101.SCH 1864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20250807_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20250807_pre.xml EX-101.PRE 12591
15 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20250807_htm.xml XML 2815
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)